Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PFE | 36.00% | $149.67B | -6.74% | 6.32% |
NVS | 35.93% | $194.42B | -7.73% | 3.76% |
AZN | 34.41% | $202.69B | -2.82% | 2.27% |
BUD | 33.90% | $81.35B | -26.91% | 1.87% |
SNY | 33.42% | $120.91B | -6.03% | 4.11% |
SNN | 33.33% | $10.42B | -11.45% | 3.06% |
EHC | 33.20% | $9.38B | +30.24% | 0.68% |
REGN | 31.58% | $75.92B | -26.29% | 0.00% |
XYL | 31.02% | $28.04B | +4.02% | 1.22% |
RELX | 30.56% | $85.48B | +12.94% | 1.65% |
JNJ | 30.46% | $348.50B | -9.82% | 3.38% |
CCEP | 30.43% | $34.66B | +11.94% | 2.74% |
KO | 30.30% | $267.26B | +3.42% | 3.11% |
PLD | 30.27% | $100.14B | -16.81% | 3.45% |
PSA | 29.40% | $50.80B | -1.65% | 4.01% |
IDXX | 29.08% | $34.28B | -19.49% | 0.00% |
TMO | 29.03% | $213.05B | +2.77% | 0.28% |
QGEN | 28.97% | $10.11B | -2.01% | 0.00% |
WM | 27.91% | $83.15B | +14.60% | 1.44% |
PAC | 27.75% | $8.31B | +25.81% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HUSA | -19.93% | $21.33M | 0.00% | 0.00% |
GPCR | -18.24% | $1.45B | -43.39% | 0.00% |
COHR | -17.20% | $14.38B | +105.93% | 0.00% |
GRND | -16.23% | $2.94B | +88.68% | 0.00% |
DAKT | -12.95% | $773.86M | +107.95% | 0.00% |
NINE | -12.88% | $49.57M | -50.21% | 0.00% |
DKL | -12.73% | $2.25B | +0.25% | 9.83% |
GEO | -12.48% | $4.43B | +194.88% | 0.00% |
RRC | -12.19% | $9.56B | +33.40% | 0.80% |
AGIO | -11.59% | $1.90B | +51.87% | 0.00% |
LNG | -11.50% | $54.54B | +48.38% | 0.74% |
WMG | -11.29% | $15.33B | -17.64% | 2.35% |
EXE | -11.14% | $24.06B | +32.57% | 2.19% |
KNOP | -11.11% | $203.25M | +1.53% | 1.72% |
DTM | -10.56% | $10.92B | +100.78% | 2.68% |
TGI | -10.27% | $1.45B | +23.43% | 0.00% |
EE | -10.14% | $751.43M | +119.49% | 0.44% |
OCSL | -9.82% | - | - | 14.25% |
PRKS | -9.78% | $3.01B | +7.53% | 0.00% |
PJT | -9.72% | $3.71B | +62.68% | 0.62% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PPH | 54.00% | $543.08M | 0.36% |
IXJ | 47.94% | $3.71B | 0.41% |
IYH | 42.98% | $3.15B | 0.39% |
XLV | 42.92% | $37.44B | 0.09% |
VHT | 40.88% | $16.77B | 0.1% |
RSPH | 39.98% | $833.86M | 0.4% |
FHLC | 39.65% | $2.69B | 0.084% |
EWU | 39.28% | $2.91B | 0.5% |
SCHY | 38.77% | $780.79M | 0.14% |
KXI | 37.27% | $671.88M | 0.41% |
EFAV | 36.94% | $5.58B | 0.2% |
FLGB | 36.15% | $635.62M | 0.09% |
FXH | 35.98% | $1.08B | 0.62% |
IHE | 35.85% | $615.35M | 0.39% |
EWL | 34.40% | $1.07B | 0.5% |
ACWV | 34.39% | $3.92B | 0.2% |
GCOW | 34.06% | $1.90B | 0.6% |
HDEF | 33.73% | $1.60B | 0.09% |
EWW | 33.50% | $1.10B | 0.5% |
BBEU | 33.31% | $3.61B | 0.09% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GAN | 0.01% | $84.76M | +22.37% | 0.00% |
GTES | 0.01% | $5.19B | +53.12% | 0.00% |
CODI | -0.01% | $1.61B | -1.71% | 4.57% |
CRM | -0.01% | $309.63B | +20.19% | 0.48% |
KTOS | 0.01% | $4.95B | +75.56% | 0.00% |
PSLV | -0.02% | - | - | 0.00% |
CLS | -0.02% | $12.00B | +261.66% | 0.00% |
RF | 0.03% | $21.81B | +33.70% | 3.95% |
TRVG | -0.03% | $59.69M | +6.83% | 0.00% |
HBT | -0.03% | $688.94M | +11.83% | 3.38% |
PR | -0.03% | $10.88B | +20.94% | 2.95% |
JBLU | -0.06% | $2.67B | +49.90% | 0.00% |
WSBF | 0.07% | $244.10M | -4.69% | 4.65% |
BBIO | -0.07% | $6.73B | -5.26% | 0.00% |
KGC | -0.08% | $13.03B | +88.28% | 1.13% |
FLNG | 0.09% | $1.40B | -12.41% | 11.49% |
VKTX | -0.09% | $3.78B | +59.60% | 0.00% |
MBWM | 0.09% | $701.53M | +17.05% | 3.19% |
DRI | -0.10% | $21.33B | +15.82% | 2.99% |
AMAL | 0.10% | $1.05B | +34.95% | 1.31% |
SeekingAlpha
Vaxcyte's robust financial position supports its strategic flexibility and extended timelines. Read more to see why I rate PCVX stock as a buy.
SeekingAlpha
GSK plc (NYSE:GSK) 43rd Annual J.P. Morgan Healthcare Conference January 14, 2025 10:30 AM ETCompany ParticipantsEmma Walmsley - CEOLuke Miels - Chief...
SeekingAlpha
The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive opportunities for investors.
SeekingAlpha
On Wednesday, the Bureau of Labor Statistics will release the consumer price index for December 2024. Check out my thoughts on how markets could react.
SeekingAlpha
CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock.
SeekingAlpha
Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects for 2025.
Current Value
$32.791 Year Return
Current Value
$32.791 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | -20.54% | $390.63M | 0.5% |
UUP | -17.08% | $640.67M | 0.77% |
TPMN | -14.59% | $41.70M | 0.65% |
VIXY | -13.45% | $195.31M | 0.85% |
DBE | -13.32% | $50.63M | 0.77% |
CANE | -13.01% | $12.08M | 0.29% |
UNG | -11.55% | $820.81M | 1.06% |
DBO | -11.42% | $228.06M | 0.77% |
GSG | -9.85% | $1.07B | 0.75% |
PDBC | -9.25% | $4.29B | 0.59% |
COMT | -9.20% | $717.70M | 0.48% |
DBC | -9.15% | $1.35B | 0.87% |
USCI | -9.00% | $200.39M | 1.07% |
GCC | -7.60% | $132.73M | 0.55% |
CTA | -6.81% | $536.34M | 0.76% |
EQLS | -6.70% | $8.93M | 1% |
FTGC | -6.39% | $2.33B | 1.02% |
DBA | -6.31% | $812.87M | 0.93% |
BCI | -5.47% | $1.36B | 0.26% |
FCG | -5.09% | $445.24M | 0.6% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DBB | 0.01% | $109.41M | 0.77% |
JETS | 0.10% | $1.06B | 0.6% |
KRE | -0.14% | $4.80B | 0.35% |
TAIL | -0.22% | $65.48M | 0.59% |
IEZ | 0.22% | $167.15M | 0.4% |
ICLO | -0.25% | $287.48M | 0.2% |
FENY | 0.30% | $1.55B | 0.084% |
YEAR | 0.32% | $1.19B | 0.25% |
ARKB | 0.38% | $4.24B | 0.21% |
DAPP | -0.39% | $190.79M | 0.51% |
BITO | 0.41% | $2.37B | 0.95% |
SATO | 0.45% | $11.45M | 0.6% |
MLPX | -0.45% | $2.57B | 0.45% |
BKCH | 0.46% | $173.09M | 0.5% |
BOXX | 0.49% | $4.73B | 0.1949% |
DEFI | 0.53% | $14.87M | 0.94% |
OIH | 0.60% | $1.54B | 0.35% |
VDE | 0.60% | $7.86B | 0.1% |
BIZD | -0.64% | $1.37B | 13.33% |
MAGS | 0.69% | $1.82B | 0.29% |